Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-10 Purchase |
2022-04-05 07:24 am |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) |
View |
| 2022-02-10 Purchase |
2022-04-05 07:22 am |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
333,333 | $15 | $4,999,995 | 3,429,927 (Indirect) |
View |
| 2022-02-10 Purchase |
2022-02-14 6:17 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES Katabi Maha 10% Owner |
266,666 | $15 | $3,999,990 | 3,181,442 (Direct) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:23 pm |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
727,272 | $11 | $7,999,992 | 2,914,776 (Direct) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:20 pm |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:17 pm |
Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner |
727,272 | $11 | $7,999,992 | 2,914,776 (Indirect) |
View |
| 2021-05-18 Purchase |
2021-05-18 8:14 pm |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
909,090 | $11 | $9,999,990 | 3,096,594 (Indirect) |
View |
| 2021-05-17 Purchase |
2021-05-18 8:10 pm |
Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director |
790,555 | $11.02 | $8,714,653 | 2,978,059 (Indirect Direct) |
View |
| 2021-05-18 Purchase |
2021-05-18 6:00 pm |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
772,727 | $11 | $8,499,997 | 2,970,156 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-24 Option Award |
2022-05-26 4:16 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | Hall Kimball Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:14 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:13 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:11 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:09 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | Morrison Scott W Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:06 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-25 4:18 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | MORRISSEY MICHAEL Director |
40,000 | $0 | 40,000 (Direct) |
View |
Ownership |
2022-05-25 4:14 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | MORRISSEY MICHAEL Director |
0 | $0 | 0 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:12 pm |
N/A 2032-02-15 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
52,964 | $0 | 52,964 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:11 pm |
N/A 2032-02-15 |
Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer |
52,412 | $0 | 52,412 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:10 pm |
N/A 2032-02-15 |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
36,729 | $0 | 36,729 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:09 pm |
N/A 2032-02-15 |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 4:07 pm |
N/A 2032-02-15 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
176,154 | $0 | 176,154 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-13 4:06 pm |
N/A 2031-12-09 |
Vera Therapeutics Inc. | VERA | Hall Kimball Director |
19,850 | $0 | 19,850 (Direct) |
View |
Ownership |
2021-12-13 4:02 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Hall Kimball Director |
0 | $0 | 0 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-15 4:22 pm |
N/A 2031-07-12 |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
180,000 | $0 | 180,000 (Direct) |
View |
Ownership |
2021-07-15 4:21 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Grant Sean Chief Financial Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:23 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
2,187,504 | $0 | 2,914,776 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:20 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Longitude Capital Partners IV LLC Longitude Venture Partners IV L.P. Tammenoms Bakker Juliet 10% Owner |
2,187,504 | $0 | 3,096,594 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:17 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner |
2,187,504 | $0 | 2,914,776 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:15 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
1,343,152 | $0 | 1,343,152 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:14 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
2,187,504 | $0 | 3,096,594 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:12 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
17,488 | $0 | 17,488 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:10 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director |
2,187,504 | $0 | 2,978,059 (Indirect) |
View |
| 2021-05-18 Conversion |
2021-05-18 6:00 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
2,187,504 | $0 | 2,970,156 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-18 6:00 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Abingworth LLP 10% Owner |
9,925 | $0 | 2,970,156 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:41 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Morrison Scott W Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:40 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Katabi Maha Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:38 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | SEIDENBERG BETH C Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:36 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | ENRIGHT PATRICK G Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:35 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:34 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | EMSTER KURT VON Director 10% Owner |
9,925 | $0 | 9,925 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:33 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Lin Celia Chief Medical Officer |
16,916 | $0 | 16,916 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:32 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Curley Joanne Chief Development Officer |
108,217 | $0 | 108,217 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:30 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Young Joseph R SVP, Finance, Chief Acct Offcr |
13,722 | $0 | 13,722 (Direct) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:28 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Fordyce Marshall President and CEO |
110,038 | $0 | 110,038 (Direct) |
View |
Ownership |
2021-05-14 09:32 am |
N/A N/A |
Vera Therapeutics Inc. | VERA | Ares Trading S.A. Merck KGaA MERCK SERONO S.A. 10% Owner |
0 | $0 | 1,913,501 (Direct) |
View |
Ownership |
2021-05-13 7:30 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Sofinnova Venture Partners X L.P. Sofinnova Management X L.L.C. HEALY JAMES POWELL MICHAEL 10% Owner |
0 | $0 | 2,187,504 (Direct) |
View |